HF
ACIU icon

HRT Financial’s AC Immune ACIU Stock Holding History

HRT Financial’s Portfolio ACIU Stock Details ACIU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-17,276
Closed -$47K – 4070
2026
Q1 		$47K Buy
+17,276
New +$53.6K ﹤0.01% 3461
2022
Q2 		– Sell
-10,520
Closed -$42K – 2846
2022
Q1 		$42K Buy
+10,520
New +$45.6K ﹤0.01% 2762
2021
Q3 		– Sell
-18,878
Closed -$149K – 3216
2021
Q2 		$149K Buy
+18,878
New +$130K ﹤0.01% 2489
2020
Q1 		– Sell
-22,354
Closed -$190K – 719
2019
Q4 		$190K Buy
+22,354
New +$149K 0.01% 954

Other funds holding ACIU

BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

HRT Financial's ACIU Position: Q2 2026 in Review

HRT Financial sold out of AC Immune (ACIU) in Q2 2026, closing a stake of 17,276 shares — an estimated $47K sold.

HRT Financial first reported a position in ACIU in Q4 2019 and held it in 4 quarters. The position peaked at $190K in Q4 2019. 43 funds tracked by Wall St. Rank hold ACIU as of Q2 2026.

  • HRT Financial reported no remaining AC Immune position as of Q2 2026 after selling out during the quarter.
  • HRT Financial sold 17,276 AC Immune shares in Q2 2026, an estimated $47K.
  • HRT Financial first reported a position in AC Immune in Q4 2019 and held it in 4 quarters.
  • HRT Financial's AC Immune position peaked at $190K in Q4 2019.
  • 43 funds tracked by Wall St. Rank held AC Immune as of Q2 2026.

Based on HRT Financial's 13F filing for Q2 2026, filed 14 Aug 2026.